Legacy Effects of Baseline Blood Pressure 'Treatment Naivety' on All-cause and Cardiovascular Mortality in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

被引：0
|
作者：
Ho, Chau
Bresliln, Monique
Chowdhury, Enayet
Doust, Jenny
Reid, Christopher M.
Davis, Barry R.
Simpson, Lara M.
Nelson, Mark R.
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11020
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The anti hypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Focus on the diabetic patient
    不详
    CURRENT HYPERTENSION REPORTS, 2004, 6 (03) : 212 - 214
  • [42] Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results by Sex
    Oparil, Suzanne
    Davis, Barry R.
    Cushman, William C.
    Ford, Charles E.
    Furberg, Curt D.
    Habib, Gabriel B.
    Haywood, L. Julian
    Margolis, Karen
    Probstfield, Jeffrey L.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    HYPERTENSION, 2013, 61 (05) : 977 - +
  • [43] Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Piller, Linda B.
    Baraniuk, Sarah
    Simpson, Lara M.
    Cushman, William C.
    Massie, Barry M.
    Einhorn, Paula T.
    Oparil, Suzanne
    Ford, Charles E.
    Graumlich, James F.
    Dart, Richard A.
    Parish, David C.
    Retta, Tamrat M.
    Cuyjet, Aloysius B.
    Jafri, Syed Z.
    Furberg, Curt D.
    Saklayen, Mohammad G.
    Thadani, Udho
    Probstfield, Jeffrey L.
    Davis, Barry R.
    CIRCULATION, 2011, 124 (17) : 1811 - U88
  • [44] Review of heart failure events in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): ALLHAT heart failure validation study
    Einhorn, P
    Davis, B
    Piller, L
    deLeon, B
    Simpson, L
    Kostis, J
    Levy, D
    Massie, B
    Nwachuku, C
    Black, H
    Cushman, W
    CIRCULATION, 2003, 108 (17) : 399 - 400
  • [45] Response to letter regarding article, "Role of diuretics in the prevention of heart failure: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)"
    Davis, Barry R.
    Piller, Linda B.
    Dunn, Kay
    CIRCULATION, 2007, 115 (02) : E19 - E19
  • [46] Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Wright, Jackson T.
    Harris-Haywood, Sonja
    Pressel, Sara
    Barzilay, Joshua
    Bairnbridge, Charles
    Bareis, Charles J.
    Basile, Jan N.
    Black, Henry R.
    Dart, Richard
    Gupta, Alok K.
    Hamilton, Bruce P.
    Einhorn, Paula T.
    Haywood, L. Julian
    Jafri, Syed Z. A.
    Louis, Gail T.
    Whelton, Paul K.
    Scott, Cranford L.
    Sinnnons, Debra L.
    Stanford, Carol
    Davis, Barry R.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) : 207 - 217
  • [47] TOWARD IDENTIFYING PERSONALIZED PROGNOSIS IN HYPERTENSION: VARIATION IN EARLY RESPONSES IN THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT)
    Dhruva, Sanket Shishir
    Huang, Chenxi
    Spatz, Erica
    Coppi, Andreas
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Xu, Xiao
    Furberg, Curt
    Davis, Barry
    Pressel, Sara
    Coifman, Ronald
    Krumholz, Harlan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1762 - 1762
  • [48] Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and other studies of hypertension
    Furberg, CD
    Psaty, BM
    Pahor, M
    Alderman, MH
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (12) : 1074 - 1078
  • [49] Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, SL
    Davis, BR
    Wright, JT
    Geraci, TS
    Kingry, C
    Ford, CE
    Piller, LB
    Bettencourt, J
    Kimmel, B
    Lusk, C
    Parks, H
    Simpson, LM
    Nwachuku, C
    Furberg, CD
    CONTROLLED CLINICAL TRIALS, 2001, 22 (01): : 29 - 41
  • [50] The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) Heart Failure Validation Study: Diagnosis and prognosis
    Einhorn, Paula T.
    Davis, Barry R.
    Massie, Barry M.
    Cushman, William C.
    Piller, Linda B.
    Simpson, Lara M.
    Levy, Daniel
    Nwachuku, Chuke E.
    Black, Henry R.
    AMERICAN HEART JOURNAL, 2007, 153 (01) : 42 - +
12345